ARCHIVES

Gastrointestinal SPORE To Be Recompeted

This article is from The Cancer Letter archive.

Vol. 21 No. 25 | June 23, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

In Brief: NCI-Litton Negations On Frederick continue; Staffs Not Worried About Possible GAO Probe

July 15, 1977

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Federal Hospitals Should Share Radiotherapy Facilitates: GAO

February 16, 1979